Announcement • Apr 19
Redwood Scientific Technologies Inc. Announces a Strategic Shift in its Product Development Priorities Redwood Scientific Technologies Inc. announced a strategic shift in its product development priorities. The New York-based firm will only focus on enhancing and expanding its nicotine replacement therapy (NRT) products, specifically TBX-FREE and TBX VAPE-FREE. This pivotal decision follows recent findings published by the American College of Cardiology, sourced from a study conducted by the National Institute of Health. The study highlights a significant correlation between e-cigarette use and an increased risk of heart failure, underscoring the urgency for effective and safe alternatives in nicotine replacement therapy. Redwood believes that its TBX-FREE and TBX VAPE-FREE products will be innovative solutions in the realm of nicotine replacement therapy. The company anticipates publication of double blind randomized studies before bringing these products to market. By concentrating its resources on TBX-FREE and TBX VAPE-FREE, Redwood is positioning itself to be at the forefront of a critical market, responding proactively to the latest scientific research and public health needs. Announcement • Feb 07
Redwood Scientific Technologies Inc. Enters into an Agreement with Jeeva Clinical Trials to Launch Clinical Effectiveness Study of its TBX-Free Oral Strips Products for Smoking and E-Cortation Redwood Scientific Technologies Inc. announced that it has entered into an agreement with Jeeva Clinical Trials to launch a clinical effectiveness study of its TBX-Free oral strips products for smoking and e- vaping cessation. The company has engaged top U.S. institution, George Mason University, to conduct the efficacy study on this new product. nicotine - found in cigarettes, vapes and e- vaping - is highly addictive, acting as both a stimulant and a sedative, and has severe adverse effects on every bodily system. It has been reported that 8 million adults in the U.S. regularly use e- vaping, with 28.3 million adults who regularly use traditional cigarettes. Of this number of users, 2.5 million middle and high school students use e- vaping, with 16.5% of high school students report current use of tobacco. The CDC reported that 60% of youth tobacco users have made an attempt to quit. It has also been reported that 54% of e- vaping users have also tried to quit. Unfortunately, nicotine replacement therapies (NRTs) that are currently on the market still rely on the continued use of nicotine. These products include nicotine patches, nasal sprays, gum, and other over the counter, standard-of-care aids that are available. Redwood's TBX-free dissolvable oral strips are nicotine free and rely on the power of cytisine, a more effective active ingredient that is found in golden rain trees (Cytisus Laburnum), mainly in the seeds. Cytisine acts similarly to nicotine where it can stimulate receptors in the brain, nearly identical to e- vaping, allowing the brain to overcome the craving to vape with a lower risk of addiction. Announcement • Nov 16
Redwood Scientific Technologies Receives Conditional Approval from Irb/Cirb for Groundbreaking Clinical Studies Redwood Scientific Technologies announced that, as of 11-13-2023 at 10:42 AM, it has secured conditional approval from the Institutional Review Board (IRB)/Central Institutional Review Board (CIRB). This milestone marks a significant advancement in Redwood's ongoing efforts towards clinical study work, aiming to develop and introduce an Oral Thin Film Strip to address nicotine addiction in vape devices. The conditional IRB approval not only paves the way for the study on Redwood's innovative product for nicotine addiction in vape devices but also extends to a study on TBX FREE, the company's primary product designed to combat nicotine addiction in traditional cigarettes. Redwood envisions being the pioneer in the market with a nicotine-free solution for addiction to nicotine in e- vape devices. This conditional approval from IRB/CIRB signifies a crucial step forward for Redwood Scientific Technologies in its commitment to addressing nicotine addiction across various mediums. The company remains dedicated to accelerating the development and market availability of these solutions to make a meaningful impact on the current challenges associated with nicotine dependency. 
